KRAZATI Trademark

Trademark Overview


On Tuesday, August 9, 2022, a trademark application was filed for KRAZATI with the United States Patent and Trademark Office. The USPTO has given the KRAZATI trademark a serial number of 97541695. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by Mirati Therapeutics, Inc.. The KRAZATI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
krazati

General Information


Serial Number97541695
Word MarkKRAZATI
Filing DateTuesday, August 9, 2022
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7020760
Registration DateTuesday, April 4, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized term "KRAZATI", with the "K" in blue and green and the remaining letters in blue, the blue letters in gradient from a darker blue at the bottom of the letters to a lighter blue toward the top. The white in this mark drawing represents background and/or transparent areas only and is not claimed as a feature of this mark.
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Goods and Servicesresearch and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 29, 2022
Primary Code042
First Use Anywhere DateTuesday, December 13, 2022
First Use In Commerce DateTuesday, December 13, 2022

Trademark Owner History


Party NameMirati Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirati Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirati Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, September 28, 2022ASSIGNED TO EXAMINER
Friday, August 12, 2022NEW APPLICATION ENTERED
Monday, August 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 30, 2022TEAS STATEMENT OF USE RECEIVED
Friday, December 30, 2022USE AMENDMENT FILED
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 30, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 2, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED